Regulatory Top Stories SurGenTec® Breaks New Ground with FDA Clearance for OsteoFlo® HydroFiber™, Receives Indication for Stand-Alone Use Equivalent to Autograft byJosh SandbergJanuary 16, 2025
Biologics Regulatory Spine Top Stories SurGenTec Receives FDA Clearance for B-MAN Bone Marrow Aspirate Kit with Integrated Filtration byTim AllenAugust 27, 2024
Regulatory Spine Top Stories SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft byJosh SandbergMarch 7, 2024
Regulatory Spine Top Stories SurGenTec® Unveils TiLink™—Revolutionary Posterior Sacroiliac Fusion System Featuring Novel Compression Capability byJosh SandbergOctober 3, 2023
Regulatory Spine Top Stories SurGenTec’s TiLink-L Receives FDA Clearance, Leading the Way as the First Offering in its Advanced Sacroiliac Joint Fusion Portfolio byJosh SandbergJune 9, 2023
Spine Top Stories SurGenTec Launches ION Screw, Smallest Posterior Spinal Fixation Implant, to Market After Receiving FDA Clearance byJosh SandbergMarch 2, 2022
Spine SurGenTec’s 3D GraftRasp™ Awarded Best Spine Technology for 2020 byJosh SandbergNovember 25, 2020
Biologics Regulatory Spine SurGenTec® Announces First-of-its-Kind FDA Clearance for its 3D GraftRasp System™ Including Key Spine Indications byJosh SandbergOctober 1, 2020
Biologics Regulatory Spine SurGenTec® Announces FDA Clearance for OsteoFlo® NanoPutty® (Quadphasic Synthetic Bone Graft) byJosh SandbergAugust 26, 2020
